FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090732 [Registered on: 11/07/2025] Trial Registered Prospectively
Last Modified On: 10/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to see how effective two herbal oil treatments are (Kumari Siddha Taila and Shatpushpa Siddha Taila) when used as enemas for helping women with PCOS who arent ovulating. 
Scientific Title of Study   A RANDOMISED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF KUMARI SIDDHA TAILA MATRABASTI AND SHATPUSHPA SIDDHA TAILA MATRABASTI IN ANOVULATORY CYCLE IN ANOVULATORY CYCLE IN PCOS  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSampada Anil Shinde 
Designation  PG Scholar  
Affiliation  Tilak ayurvedic mahavidyalaya rasta peth pune 
Address  Tilak Ayurved Mahavidyalaya Department of stress Roga and Prasuti-Tantra 1st floor 583/2 Rasta peth pune MAHARASHTRA 411011 India

Pune
MAHARASHTRA
411011
India 
Phone  9834620757  
Fax    
Email  Sampadashinde2000@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrRucha Ganu 
Designation  Associate professor  
Affiliation  Tilak ayurvedic mahavidyalaya rasta peth pune 
Address  Department of stress Roga and Prasuti-Tantra 1st floor 583/2 Rasta peth pune MAHARASHTRA 411011 India

Pune
MAHARASHTRA
411011
India 
Phone  9822376936  
Fax    
Email  ganu.rucha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrRucha Ganu 
Designation  Associate professor  
Affiliation  Tilak ayurvedic mahavidyalaya rasta peth pune 
Address  Department of stress Roga and Prasuti-Tantra 1st floor 583/2 Rasta peth pune MAHARASHTRA 411011 India

Pune
MAHARASHTRA
411011
India 
Phone  9822376936  
Fax    
Email  ganu.rucha@gmail.com  
 
Source of Monetary or Material Support  
Seth Tarachand Ramanath Charitable Ayurvedic Hospital pune maharashtra 411011 
 
Primary Sponsor  
Name  Tilak ayurvedic mahavidyalaya rasta peth Pune  
Address  Tilak Ayurved Mahavidyalaya Department of stress Roga and Prasuti-Tantra 1st floor 583/2 Rasta peth pune MAHARASHTRA 411011 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSampada Anil Shinde  Seth Tarachand Ramanath Charitable Ayurvedic Hospital Pune  Tilak Ayurved Mahavidyalaya Department of stress Roga and Prasuti-Tantra OPD 11 Ground floor 583/2 Rasta peth pune MAHARASHTRA 411011 India
Pune
MAHARASHTRA 
9834620757

Sampadashinde2000@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Tilak Ayurveda Mahavidyalaya  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N915||Oligomenorrhea, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Shatpushpa siddha taila, Reference: Charak sutra 4/13, Route: Rectal, Dosage Form: Taila, Dose: 50(ml), Frequency: od, Bhaishajya Kal: Sabhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Kumari siddha taila , Reference: Aayurvedvidnyan , Route: Rectal, Dosage Form: Taila, Dose: 50(ml), Frequency: od, Bhaishajya Kal: Sabhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Age group 18-35 years.
Diagnosis Ultrasound Polycystic ovarian morphology.
Diagnosed cases of PCOS with any of the following symptoms
Ovulatory dysfunction refers to Oligomenorrhea or amenorrhea.
Anovulatory Cycles
Irregular Menses/ Scanty Menses.
Hirsutism
Obesity
Acanthosis Nigricans 
 
ExclusionCriteria 
Details  Patients having history of
Systemic diseases like Diebetes mellitus, Hypertension, etc.
Irregular menses due to anatomical defect in reproductive system such as Hypoplastic Uterus,
Aplastic Uterus, Streak Ovaries, Hypogonadism.
Menorrhagia in PCOS. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The study will analyze the clinical signs and symptoms to determine the effectiveness of each treatment.   12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
No any  No ANY 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/08/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will be intervened by the treatment of Kumari siddha tail matra basti and Shatpushpa siddha taila matra basti to group A and group B respectively. The efficacy of the
therapy will be assessed on the basis of subjective and objective criteria for statistical
analysis. Scoring will be designed according to the severity of symptoms. The
subjective and objective gradation of symptoms will be done as follows and the
intensity of each symptom will be calculated before treatment, after treatment and
after follow up. The effect of treatment result will be assessed in regards to clinical
signs and symptoms on the basis of grading and scoring system. The signs and
symptoms will be assessed by adopting the suitable scoring method.
 
Close